Advertisement

Topics

Angelman Syndrome Foundation Company Profile

10:53 EDT 26th March 2019 | BioPortfolio

Since 1996, the Angelman Syndrome Foundation has funded 59 research grants totaling more than $3.5 million. The Angelman Syndrome Foundation has awarded a majority of these funds ($3.3 million) beginning in 2005. For more information on the Foundation, please visit www.angelman.org.


News Articles [1030 Associated News Articles listed on BioPortfolio]

$OVID Announces Plans to Move into a Phase 3 Trial in Pediatric Patients Based on End-of-Phase 2 Meeting for OV101 in Angelman Syndrome https://globenewswire.com/news-release/2018/12/06/1663049/0/en/Ovid-Therapeutics-Announces-Plans-to-Move-into-a-Phase-3

$OVID Announces Plans to Move into a Phase 3 Trial in Pediatric Patients Based on End-of-Phase 2 Meeting for OV101 in Angelman Syndrome https://globenewswire.com/news-release/2018/12/06/1663049/0/en...

Can Genetic Therapy Help Kids with Angelman Syndrome Overcome Seizures?

NewsAngelman syndrome is a genetic disease with no cure. Children grow up with severe intellectual disabilities and a range of other problems, arguably the worst of which are epileptic seizures.

$OVID to Host CC and Webcast on Thursday, October 25, at 10:30 a.m. EDT to review additional data from company’s Phase 2 STARS trial with OV101 for the treatment of Angelman syndrome during

$OVID to Host CC and Webcast on Thursday, October 25, at 10:30 a.m. EDT to review additional data from company’s Phase 2 STARS trial with OV101 for the treatment of Angelman syndrome during

Ovid Therapeutics Presents Additional Data and Analyses from the Phase 2 STARS Clinical Trial with OV101 for the Treatment of Angelman Syndrome at the 65th AACAP Annual Meeting

-- Additional data and analyses suggest that in the OV101 15 mg once-daily dose group, changes in sleep parameters and motor domains contributed to the statistically significant improvement in overal...

Disruptive Nutrition and Study Partners Announce First Patient Enrolled in a Clinical Research Study for Nutritional Intervention in Angelman Syndrome

Disruptive Nutrition, the keto-medical foods company, a subsidiary of Disruptive Enterprises, today announced the first patient enrolled in a clinical research study that it is co...

Ovid Therapeutics Announces Plans to Move into a Phase 3 Trial in Pediatric Patients Based on End-of-Phase 2 Meeting for OV101 in Angelman Syndrome

-- Single pivotal Phase 3 trial design, using once-daily dosing, may be sufficient for approval of OV101 in Angelman syndrome -- -- Trial initiation activities have begun for ELARA, an open-label e...

Parasites and metabolic syndrome -- Morris Animal Foundation's newest equine studies

(Morris Animal Foundation) Morris Animal Foundation is funding three new pilot studies in horse health, with a focus on equine parasitic worms and equine metabolic syndrome. The studies, collectively ...

Ovid Presents Additional Data at AACAP

As showcased in a poster presentation, the data for the disorder, called Angelman syndrome, suggests the OV101 15 mg dose has improved sleep, movement skills and behavior of the patients. The post Ovi...

Drugs and Medications [31 Associated Drugs and Medications listed on BioPortfolio]

No7 protect and perfect foundation sunscreen broad spectrum spf 15 calico [boots retail usa inc]

NA

Meloxicam [kaiser foundation hospitals]

These highlights do not include all the information needed to use MELOXICAM TABLETS USP. safely and effectively. See full prescribing information for MELOXICAM TABLETS USP. MELOXICAM Tablets USP, for ...

Benzonatate [kaiser foundation hospitals]

Benzonatate Capsules, USP 100 mg

Misoprostol [kaiser foundation hospitals]

Misoprostol Tablets 8204001/0613 Rx Only

Oxygen [cornerstone mecial services - midwest, llc]

Oxygen

PubMed Articles [2531 Associated PubMed Articles listed on BioPortfolio]

Establishment of human induced pluripotent stem cell line from a patient with Angelman syndrome carrying the deletion of maternal chromosome 15q11.2-q13.

Angelman syndrome is a rare neurodevelopmental disorder caused by the loss of function of the maternally expressed E3 ubiquitin ligase UBE3A. We established human induced pluripotent stem cells (iPSCs...

Social-emotional processing in nonverbal individuals with Angelman syndrome: evidence from brain responses to known and novel names.

The combination of intellectual, communicative and motor deficits limits the use of standardised behavioural assessments in individuals with Angelman syndrome (AS). The current study aimed to objectiv...

A proteasomal partner goes missing in Angelman syndrome.

Loss-of-function mutations in the UBE3A ubiquitin ligase are associated with Angelman syndrome (AS), a severe neurologic disorder. A new study defines the role of mutations in an N-terminal "AZUL" dom...

Electrophysiological Phenotype in Angelman Syndrome Differs Between Genotypes.

Angelman syndrome (AS) is a severe neurodevelopmental disorder caused by either disruptions of the gene UBE3A or deletion of chromosome 15 at 15q11-q13, which encompasses UBE3A and several other genes...

Generation of an iPSC line of a patient with Angelman syndrome due to an imprinting defect.

Angelman syndrome (AS) is a neurodevelopmental disorder with leading symptoms of happy demeanor, intellectual disability, ataxia and seizures. AS can be caused by genetic and epigenetic aberrations, r...

Clinical Trials [4546 Associated Clinical Trials listed on BioPortfolio]

Study on the Brain Network of Angelman Syndrome

The aims of study on Angelman syndrome: (1)establish the Angelman syndrome database (2)to study the brain Network of Angelman Syndrome Based on Multi-modal Brain Image and Neural-EEG Data

Study on Tolerability of Levodopa/Carbidopa in Children With Angelman Syndrome

This study is designed to determine the highest dose of levodopa/carbidopa that can be tolerated without any serious side effects by children with Angelman syndrome. It has been hypothesi...

Characterization of Angelman Syndrome

Angelman Syndrome (AS) is a developmental disorder that is caused by a deficiency of a maternally transmitted gene. It is inherited at birth, and affects movement, speech, and social demea...

Angelman Syndrome Italian Registry

The Italian Angelman Registry is a national registry for patients with Angelman Syndrome. No experimental intervention is involved in participation. The data provided are stored in the reg...

Dietary Supplements for the Treatment of Angelman Syndrome

Angelman syndrome (AS) is a complex genetic disorder that affects the nervous system. The purpose of this study is to determine the effectiveness of certain dietary supplements in treating...

Companies [1528 Associated Companies listed on BioPortfolio]

Angelman Syndrome Foundation

Since 1996, the Angelman Syndrome Foundation has funded 59 research grants totaling more than $3.5 million. The Angelman Syndrome Foundation has awarded a majority of these funds ($3.3 million) beginn...

Foundation for Angelman Syndrome Therapeutics (FAST)

Angelman Syndrome (AS) was first described by Dr. Harry Angelman in 1965. Common symptoms include developmental delay and intellectual disabilities, happy demeanor, movement and balance disorder, seve...

The Angelman Syndrome Foundation

Sjogren's Syndrome Foundation

Founded in 1983, the Sjogren's Syndrome Foundation (SSF) provides patients with practical information and coping strategies that minimize the effects of Sjogren's syndrome. In addition, the Foundation...

Global Down Syndrome Foundation

The Global Down Syndrome Foundation is a public non-profit 501(c)(3) dedicated to significantly improving the lives of people with Down syndrome through research, medical care, ed...

More Information about "Angelman Syndrome Foundation" on BioPortfolio

We have published hundreds of Angelman Syndrome Foundation news stories on BioPortfolio along with dozens of Angelman Syndrome Foundation Clinical Trials and PubMed Articles about Angelman Syndrome Foundation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Angelman Syndrome Foundation Companies in our database. You can also find out about relevant Angelman Syndrome Foundation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record